+44 (0)115 974 9000
Quotient Clinical is a specialist pharmaceutical R&D service business, helping customers worldwide to advance their new drugs through clinical development.
For more than 20 years, Quotient Clinical has brought innovation to the drug development process, by pioneering a unique Translational Pharmaceutics® approach which integrates formulation development, real-time GMP manufacturing and clinical testing.
The benefits of the Translational Pharmaceutics include:
- Reducing timelines and cost;
- Conserving drug substance;
- Increased precision in real-time dose selection;
- In-protocol modification of formulation composition;
- Adaptive clinical protocol design;
- Decision making based on human clinical data;
- Mitigation of development risks
Our core portfolio of services, which are underpinned by Translational Pharmaceutics, include:
- Enabled-FIH® (Enabled-First-in-Human) focused on transitioning a candidate drug molecule from preclinical research through clinical proof of concept
- RapidFACT® (Rapid Formulation development and Clinical Testing) an innovative approach that streamlines the screening and optimisation of new formulations for clinical development
- Human-ADME for companies needing to generate human metabolism and pharmacokinetic data to support drug development and registration.
Quotient Clinical’s worldwide customer base includes leading pharmaceutical and biotechnology companies in Europe, USA and Japan, ranging from large pharma to mid-size biotech.